Ravi Thadhani is a Nephrology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Renal Associates Grb 1003
Boston, MA 021142621
Telephone
617-724-1207Provider last certified this registry record 17 Mar 2020.
Clinical trials
- Study of Pregnancy Regulation of Insulin and Glucose
Sponsor: Massachusetts General Hospital
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
Sponsor: Massachusetts General Hospital
- A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
Sponsor: Deltanoid Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Orthocell LTDProgram year20251 payment$14,583openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year20231 payment
- Alnylam Pharmaceuticals Inc.Program year20223 payments$10,500openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
16 NIH research awards on record, funded 1998–2018 per NIH RePORTER. The latest:
- Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D
Massachusetts General Hospital
FY2018$440,709R01DK094486 - Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D
Massachusetts General Hospital
FY2017$440,709R01DK094486 - Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D
Massachusetts General Hospital
FY2016$440,709R01DK094486
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”